To control costs, it may be up to patients to 'pay the piper'

After many seemingly “routine” doctor’s appointments, many Americans receive their bill and try to make sense of the many ins-and-outs of deductibles, co-pays, reimbursement rules, and paperwork. They face a whirlwind of complexities that have nothing to do with buying healthcare.

Yet, as noted in a column in the Boston Globe, when providers are paid directly by patients, transactions become clear, prices decrease, bills reflect actual prices, and understanding their own healthcare becomes the norm.  

Is this a solution for lowering healthcare costs? Follow the link below for more:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.